Genomic Investigation of Cardiovascular Diseases

Active, not recruitingOBSERVATIONAL
Enrollment

15,000

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2030

Conditions
Coronary Artery DiseaseMyocardial InfarctionAtrial FibrillationAortic StenosisMitral RegurgitationIdiopathic Cardiomyopathy
Trial Locations (1)

92037

Scripps Health, La Jolla

All Listed Sponsors
lead

Scripps Translational Science Institute

OTHER

NCT00722748 - Genomic Investigation of Cardiovascular Diseases | Biotech Hunter | Biotech Hunter